Human Genome Sciences, Inc. (HGSI) Tops Q4 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts HGSI Hot Sheet
Price: $14.24 --0%
Financial Fact:
Cost of product sales: 7.88M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Financial Fact:
Cost of product sales: 7.88M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
Human Genome Sciences, Inc. (NASDAQ: HGSI) reported Q4 EPS of ($0.41), $0.02 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $45.5 million versus the consensus estimate of $42.65 million.
For earnings history and earnings-related data on Human Genome Sciences, Inc. (HGSI) click here.
For earnings history and earnings-related data on Human Genome Sciences, Inc. (HGSI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- New Break Resources plans $550,000 flow-through share offering
- Goldman Sachs Revises China Jewelry Stocks Amid Gold Price Retreat
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
